Lipoxin and aspirin-triggered lipoxins

TheScientificWorldJournal

Volumn 10, Issue , 2010, Pages 1048-1064

  Romano, Mario ^a  

^a UNIVERSITY OF CHIETI   (Italy)

Author keywords

Arachidonic acid; Aspirin; Cyclooxygenase; Inflammation; Lipoxin; Lipoxygenase; Receptor

Indexed keywords

ACETYLSALICYLIC ACID; ARACHIDONATE 12 LIPOXYGENASE; ARACHIDONATE 15 LIPOXYGENASE; ARACHIDONATE 5 LIPOXYGENASE; CYCLOOXYGENASE 2; GAMMA INTERFERON; HEME OXYGENASE 1; HYDROXYICOSATETRAENOIC ACID; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LEUKOTRIENE A4; LIPOXIN A; LIPOXIN B; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN A; VASCULOTROPIN C; VASCULOTROPIN RECEPTOR 2; LIPOXIN; LIPOXYGENASE;

ACUTE LUNG INJURY; ALLERGIC RHINITIS; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ASTHMA; ATHEROSCLEROSIS; BONE MARROW CELL; CHEMICAL STRUCTURE; CHEMOTAXIS; CYSTIC FIBROSIS; CYTOKINE RELEASE; DISEASE MODEL; ENZYME METABOLISM; ENZYME SUBSTRATE COMPLEX; EYE INJURY; FATTY ACID SYNTHESIS; GASTROINTESTINAL DISEASE; GLOMERULONEPHRITIS; HUMAN; KIDNEY DISEASE; LYMPHOCYTE; MACROPHAGE; MYCOBACTERIUM TUBERCULOSIS; NEUTROPHIL; NONHUMAN; PERIODONTITIS; PLEURISY; PORPHYROMONAS GINGIVALIS; RECEPTOR UPREGULATION; REPERFUSION INJURY; RESPIRATORY TRACT DISEASE; REVIEW; RHEUMATOID ARTHRITIS; STOMACH INJURY; THERMAL INJURY; TOXOPLASMA GONDII; TUBERCULOSIS; VASCULITIS; ANIMAL; BIOSYNTHESIS; METABOLISM;

ANIMALIA;

ANIMALS; ASPIRIN; DISEASE MODELS, ANIMAL; LIPOXINS; LIPOXYGENASE;

EID: 77953408091     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/tsw.2010.113     Document Type: Review

References (123)

1. Serhan, C.N., Hamberg, M., and Samuelsson, B. (1984) Trihydroxytetraenes: a novel series of compounds formed from arachidonic acid in human leukocytes. Biochem. Biophys. Res. Commun. 118, 943-949. (Pubitemid 14194804)
2. Serhan, C.N., Hamberg, M., and Samuelsson, B. (1984) Lipoxins: novel series of biologically active compounds formed from arachidonic acid in human leukocytes. Proc. Natl. Acad. Sci. U. S. A. 81, 5335-5339. (Pubitemid 14048742)
3. Serhan, C.N., Nicolaou, K.C., Webber, S.E., Veale, C.A., Dahlen, S.E., Puustinen, T.J., and Samuelsson, B. (1986) Lipoxin A. Stereochemistry and biosynthesis. J. Biol. Chem. 261, 16340-16345.
4. Serhan, C.N., Hamberg, M., Samuelsson, B., Morris, J., and Wishka, D.G. (1986) On the stereochemistry and biosynthesis of lipoxin B. Proc. Natl. Acad. Sci. U. S. A. 83, 1983-1987.
5. Romano, M. (2006) Lipid mediators: lipoxin and aspirin-triggered 15-epi-lipoxins. Inflamm. Allergy Drug Targets 5, 81-90.
6. Chavis, C., Vachier, I., Chanez, P., Bousquet, J., and Godard, P. (1996) 5(S),15(S)-dihydroxyeicosatetraenoic acid and lipoxin generation in human polymorphonuclear cells: dual specificity of 5-lipoxygenase towards endogenous and exogenous precursors. J. Exp. Med. 183, 1633-1643. (Pubitemid 26134305)
7. Serhan, C.N., Hirsch, U., Palmblad, J., and Samuelsson, B. (1987) Formation of lipoxin A by granulocytes from eosinophilic donors. FEBS Lett. 217, 242-246. (Pubitemid 17086752)
8. Levy, B.D., Romano, M., Chapman, H.A., Reilly, J.J., Drazen, J., and Serhan, C.N. (1993) Human alveolar macrophages have 15-lipoxygenase and generate 15(S)-hydroxy-5,8,11-cis-13-trans-eicosatetraenoic acid and lipoxins. J. Clin. Invest. 92, 1572-1579. (Pubitemid 23273940)
9. Edenius, C., Kumlin, M., Bjork, T., Anggard, A., and Lindgren, J.A. (1990) Lipoxin formation in human nasal polyps and bronchial tissue. FEBS Lett. 272, 25-28. (Pubitemid 20348973)
10. Genis, P., Jett, M., Bernton, E.W., Boyle, T., Gelbard, H.A., Dzenko, K., Keane, R.W., Resnick, L., Mizrachi, Y., Volsky, D.J., Epstein, L.G., and Gendelman, H.E. (1992) Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: implications for the neuropathogenesis of HIV disease. J. Exp. Med. 176, 1703-1718.
11. Munger, K.A., Montero. A., Fukunaga, M., Uda, S., Yura, T., Imal, E., Kaneda, Y., Valdlvielso, J.M., and Badr, K.F. (1999) Transfection of rat kidney with human 15-lipoxygenase suppresses inflammation and preserves function in experimental glomerulonephritis. Proc. Natl. Acad. Sci. U. S. A. 96, 13375-13380.
12. Edenius, C., Haeggstrom, J., and Lindgren, J.A. (1988) Transcellular conversion of endogenous arachidonic acid to lipoxins in mixed human platelet-granulocyte suspensions. Biochem. Biophys. Res. Commun. 157, 801-807. (Pubitemid 19021250)
13. Serhan, C.N. and Sheppard, K.A. (1990) Lipoxin formation during human neutrophil-platelet interactions. Evidence for the transformation of leukotriene A4 by platelet 12-lipoxygenase in vitro. J. Clin. Invest. 85, 772-780.
14. Fiore, S. and Serhan, C.N. (1990) Formation of lipoxins and leukotrienes during receptor-mediated interactions of human platelets and recombinant human granulocyte/macrophage colony-stimulating factor-primed neutrophils. J. Exp. Med. 172, 1451-1457.
15. Sheppard, K.A., Greenberg, S.M., Funk, C.D., Romano, M., and Serhan, C.N. (1992) Lipoxin generation by human megakaryocyte-induced 12-lipoxygenase. Biochim. Biophys. Acta 1133, 223-234.
16. Romano, M. and Serhan, C.N. (1992) Lipoxin generation by permeabilized human platelets. Biochemistry 31, 8269-8277.
17. Romano, M., Chen, X.S., Takahashi, Y., Yamamoto, S., Funk, C.D., and Serhan, C.N. (1993) Lipoxin synthase activity of human platelet 12-lipoxygenase. Biochem. J. 296, 127-133.
18. Brezinski, D.A., Nesto, R.W., and Serhan, C.N. (1992) Angioplasty triggers intracoronary leukotrienes and lipoxin A4. Impact of aspirin therapy. Circulation 86, 56-63.
19. Gangemi, S., Luciotti, G., D'Urbano, E., Mallamace, A., Santoro, A., Bellinghieri, G., Davì, G., and Romano, M. (2003) Physical exercise increases urinary excretion of lipoxin A4 and related compounds. J. Appl. Physiol. 94, 2237-2240.
20. Rowley, A.F., Lloyd-Evans, P., Barrow, S., and Serhan, C.N. (1994) Lipoxin biosynthesis by trout macrophages involves the formation of epoxide intermediates. Biochemistry 33, 856-863.
21. Claria, J. and Serhan, C.N. (1995) Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions. Proc. Natl. Acad. Sci. U. S. A. 92, 9475-9479.
22. Holzman, M.J., Turk, J., and Shornick, I.P. (1992) Identification of a pharmacologically distinct prostaglandin H synthase in cultured epithelial cells. J. Biol. Chem. 267, 21438-21445.
23. Claria, J., Lee, M.H., and Serhan, C.N. (1996) Aspirin-triggered lipoxins (15-epi-LX) are generated by the human lung adenocarcinoma cell line (A549)-neutrophil interactions and are potent inhibitors of cell proliferation. Mol. Med. 2, 583-596.
24. Titos, E., Chiang, N., Serhan, C.N., Romano, M., Gaya, J., Pueyo, G., and Claria, J. (1999) Hepatocytes are a rich source of novel aspirin-triggered 15-epi-lipoxin A(4). Am. J. Physiol. 277, C870-877.
25. Brezinski, D. and Serhan, C.N. (1991) Characterization of lipoxins by combined gas chromatography and electron-capture negative ion chemical ionization mass spectrometry: formation of lipoxin A4 by stimulated human whole blood. Biol. Mass Spectr. 20, 45-52.
26. Sanak, M., Levy, B.D., Clish, C.B., Chiang, N., Gronert, K., Mastalerz, L., Serhan, C.N., and Szczeklik, A. (2000) Aspirin-tolerant asthmatics generate more lipoxins than aspirin-intolerant asthmatics. Eur. Respir. J. 16, 44-49.
27. Fiorucci, S., Santucci, L., Wallace, J.L., Sardina, M., Romano, M., Del Soldato, P., and Morelli, A. (2003) Interaction of a selective cyclooxygenase-2 inhibitor with aspirin and NO-releasing aspirin in the human gastric mucosa. Proc. Natl. Acad. Sci. U. S. A. 100, 10937-109341.
28. Chiang, N., Bermudez, E.A., Ridker, P.M., Hurwitz, S., and Serhan, C.N. (2004) Aspirin triggers antiinflammatory 15-epi-lipoxin A4 and inhibits thromboxane in a randomized human trial. Proc. Natl. Acad. Sci. U. S. A. 101, 15178-15183.
29. Birnbaum, Y., Ye, Y., Lin, Y., Freeberg, S.Y., Nishi, S.P., Martinez, J.D., Huang, M.H., Uretsky, B.F., and Perez-Polo, .JR. (2006) Augmentation of myocardial production of 15-epi-lipoxin-a4 by pioglitazone and atorvastatin in the rat. Circulation 114, 929-935.
30. Planagumà, A., Pfeffer, M.A., Rubin, G., Croze, R., Uddin, M., Serhan, C.N., and Levy, B.D. (2010) Lovastatin decreases acute mucosal inflammation via 15-epi-lipoxin A(4) Mucosal Immunol. 3, 270-279.
31. Serhan, C.N., Maddox, J.F., Petasis, N.A., Akritopoulou-Zanze, I., Papayianni, A., Brady, H.R., Colgan, S.P., and Madara, J.L. (1995) Design of lipoxin A4 stable analogs that block transmigration and adhesion of human neutrophils. Biochemistry 34, 14609-14615.
32. Colgan, S.P., Serhan, C.N., Parkos, C.A., Delp-Archer, C., and Madara, J.L. (1993) Lipoxin A4 modulates transmigration of human neutrophils across intestinal epithelial monolayers. J. Clin. Invest. 92, 75-82.
33. Scalia, R., Gefen, J., Petasis, N.A., Serhan, C.N., and Lefer, A.M. (1997) Lipoxin A4 stable analogs inhibit leukocyte rolling and adherence in the rat mesenteric microvasculature: role of P-selectin. Proc. Natl. Acad. Sci. U. S. A. 94, 9967-9972.
34. Fierro, I.M., Colgan, S.P., Bernasconi, G., Petasis, N.A., Clish, C.B., Arita, M., and Serhan, C.N. (2003) Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit human neutrophil migration: comparisons between synthetic 15 epimers in chemotaxis and transmigration with microvessel endothelial cells and epithelial cells. J. Immunol. 170, 2688-2694.
35. Soyombo, O., Spur, B.W., and Lee, T.H. (1994) Effects of lipoxin A4 on chemotaxis and degranulation of human eosinophils stimulated by platelet-activating factor and N-formyl-L-methionyl-L-leucyl-L-phenylalanine. Allergy 49, 230-234.
36. Bandeira-Melo, C., Bozza, P.T., Diaz, B.L., Cordeiro, R.S., Jose, P.J., Martins, M.A., and Serhan, C.N. (2000) Cutting edge: lipoxin (LX) A4 and aspirin-triggered 15-epi-LXA4 block allergen-induced eosinophil trafficking. J. Immunol. 164, 2267-2271.
37. Maddox, J.F. and Serhan, C.N. (1996) Lipoxin A4 and B4 are potent stimuli for human monocyte migration and adhesion: selective inactivation by dehydrogenation and reduction. J. Exp. Med. 183, 137-146.
38. Romano, M., Maddox, J.F., and Serhan, C.N. (1996) Activation of human monocytes and the acute monocytic leukemia cell line (THP-1) by lipoxins involves unique signaling pathways for lipoxin A4 versus lipoxin B4: evidence for differential Ca2+ mobilization. J. Immunol. 157, 2149-2154.
39. Godson, C., Mitchell, S., Harvey, K., Petasis, N.A., Hogg, N., and Brady, H.R. (2000) Cutting edge: lipoxins rapidly stimulate nonphlogistic phagocytosis of apoptotic neutrophils by monocyte-derived macrophages. J. Immunol.164, 1663-1667.
40. Jozsef, L., Zouki, C., Petasis, N.A., Serhan, C.N., and Filep, J.G. (2002) Lipoxin A4 and aspirin-triggered 15-epilipoxin A4 inhibit peroxynitrite formation, NF-kappa B and AP-1 activation, and IL-8 gene expression in human leukocytes. Proc. Natl. Acad. Sci. U. S. A. 99, 13266-13271.
41. Gewirtz, A.T., Fokin, V.V., Petasis, N.A., Serhan, C.N., and Madara, J.L. (1999) LXA4, aspirin-triggered 15-epi-LXA4, and their analogs selectively downregulate PMN azurophilic degranulation. Am. J. Physiol. 276, C988-994.
42. Sodin-Semrl, S., Taddeo, B., Tseng, D., Varga, J., and Fiore, S. (2000) Lipoxin A4 inhibits IL-1 beta-induced IL-6, IL-8, and matrix metalloproteinase-3 production in human synovial fibroblasts and enhances synthesis of tissue inhibitors of metalloproteinases. J. Immunol. 164, 2660-2666.
43. Hachicha, M., Pouliot, M., Petasis, N.A., and Serhan, C.N. (1999) Lipoxin (LX)A4 and aspirin-triggered 15-epi-LXA4 inhibit tumor necrosis factor 1alpha-initiated neutrophil responses and trafficking: regulators of a cytokine-chemokine axis. J. Exp. Med. 189, 1923-1930.
44. Bannenberg, G.L., Chiang, N., Ariel, A., Arita, M., Tjonahen, E., Gotlinger, K.H., Hong, S., and Serhan, C.N. (2005) Molecular circuits of resolution: formation and actions of resolvins and protectins. J. Immunol. 174, 4345-4355.
45. Cezar-de-Mello, P.F., Vieira, A.M., Nascimento-Silva, V., Villela, C.G., Barja-Fidalgo, C., and Fierro, I.M. (2008) ATL-1, an analogue of aspirin-triggered lipoxin A4, is a potent inhibitor of several steps in angiogenesis induced by vascular endothelial growth factor. Br. J. Pharmacol. 153, 956-965.
46. Baker, N., O'Meara, S.J., Scannell, M., Maderna, P., and Godson, C. (2009) Lipoxin A4: anti-inflammatory and antiangiogenic impact on endothelial cells. J. Immunol. 182, 3819-3826.
47. Leedom, A.J., Sullivan, A.B., Dong, B., Lau, D., and Gronert, K. (2010) Endogenous LXA4 circuits are determinants of pathological angiogenesis in response to chronic injury. Am. J. Pathol. 176, 74-84.
48. Rodgers, K., McMahon, B., Mitchell, D., Sadlier, D., and Godson, C. (2005) Lipoxin A4 modifies platelet-derived growth factor-induced pro-fibrotic gene expression in human renal mesangial cells. Am. J. Pathol. 167, 683-694.
49. Martins, V., Valença, S.S., Farias-Filho, F.A., Molinaro, R., Simões, R.L., Ferreira, T.P., e Silva, P.M., Hogaboam, C.M., Kunkel, S.L., Fierro, I.M., Canetti, C., and Benjamim, C.F. (2009) ATLa, an aspirin-triggered lipoxin A4 synthetic analog, prevents the inflammatory and fibrotic effects of bleomycin-induced pulmonary fibrosis. J. Immunol. 182, 5374-5381.
50. Serhan, C.N., Fiore, S., Brezinski, D.A., and Lynch, S. (1993) Lipoxin A4 metabolism by differentiated HL-60 cells and human monocytes: conversion to novel 15-oxo and dihydro products. Biochemistry 32, 6313-6319.
51. Clish, C.B., Levy, B.D., Chiang, N., Tai, H.-H., and Serhan, C.N. (2000) Oxidoreductases in lipoxin A4 metabolic inactivation: a novel role for 15-onoprostaglandin 13-reductase/leukotriene B4 12-hydroxydehydrogenase in inflammation. J. Biol. Chem. 275, 25372-25380.
52. Maddox, J.F. and Serhan, C.N. (1996) Lipoxin A4 and B4 are potent stimuli for human monocyte migration and adhesion: selective inactivation by dehydrogenation and reduction. J. Exp. Med. 183, 137-146.
53. Sumimoto, H., Isobe, R., Mizukami, Y., and Minakami, S. (1993) Formation of a novel 20-hydroxylated metabolite of lipoxin A4 by human neutrophil microsomes. FEBS Lett. 315, 205-210.
54. Mizukami, Y., Sumimoto, H., Isobe, R., and Minakami, S. (1993) Omega-hydroxylation of lipoxin B4 by human neutrophil microsomes: identification of omega-hydroxy metabolite of lipoxin B4 and catalysis by leukotriene B4 omega-hydroxylase (cytochrome P-450LTB omega). Biochim. Biophys. Acta 1168, 87-93.
55. Mizukami, Y., Sumimoto, H., Isobe, R., Minakami, S., and Takeshige, K. (1994) omega-Oxidation of lipoxin B4 by rat liver. Identification of an omega-carboxy metabolite of lipoxin B4. Eur. J. Biochem. 224, 959-965.
56. Clish, C.B., O'Brien, J.A., Gronert, K., Stahl, G.L., Petasis, N.A., and Serhan, C.N. (1999) Local and systemic delivery of a stable aspirin-triggered lipoxin prevents neutrophil recruitment in vivo. Proc. Natl. Acad. Sci. U. S. A. 96, 8247-8252.
57. Guilford, W.J., Bauman, J.G., Werner Skuballa, W., Shawn Bauer, S., Wei, G.P., Davey, D., Schaefer, C., Mallari, C., Terkelsen, J., Tseng, J.-L., Shen, J., Subramanyam, B., Schottelius, A.J., and Parkinson, J.F. (2004) Novel 3-oxa lipoxin A4 analogues with enhanced chemical and metabolic stability have anti-inflammatory activity in vivo. J. Med. Chem. 47, 2157-2165.
58. O'Sullivan, T.P., Vallin, K.S., Shah, S.T., Fakhry, J., Maderna, P., Scannell, M., Sampaio, A.L., Perretti, M., Godson, C., and Guiry, P.J. (2007) Aromatic lipoxin A4 and lipoxin B4 analogues display potent biological activities. J. Med. Chem. 50, 5894-5902.
59. Duffy, C.D., Maderna, P., McCarthy, C., Loscher, C.E., Godson, C., and Guiry, P.J. (2010) Synthesis and biological evaluation of pyridine-containing lipoxin A(4) analogues. Chem. Med. Chem. 5, 517-522.
60. Sun, Y.P., Tjonahen, E., Keledjian, R., Zhu, M., Yang, R., Recchiuti, A., Pillai, P.S., Petasis, N.A., and Serhan, C.N. (2009) Anti-inflammatory and pro-resolving properties of benzo-lipoxin A(4) analogs. Prostaglandins Leukot. Essent. Fatty Acids 81, 357-366.
61. Navarro-Xavier, R.A., Newson, J., Silveira, V.L., Farrow, S.N., Gilroy, D.W., and Bystrom, J. (2010) A new strategy for the identification of novel molecules with targeted proresolution of inflammation properties. J. Immunol. 184, 1516-1525.
62. Christie, P.E., Spur, B.W., and Lee, T.H. (1992) The effects of lipoxin A4 on airway responses in asthmatic subjects. Am. Rev. Respir. Dis. 145, 1281-1284.
63. Levy, B.D., Lukacs, N.W., Berlin, A.A., Schmidt, B., Guilford, W.J., Serhan, C.N., and Parkinson, J.F. (2007) Lipoxin A4 stable analogs reduce allergic airway responses via mechanisms distinct from CysLT1 receptor antagonism. FASEB J. 21, 3877-3884.
64. Levy, B.D., De Sanctis, G.T., Devchand, P.R., Kim, E., Ackerman, K., Schmidt, B.A., Szczeklik, W., Drazen, J.M., and Serhan, C.N. (2002) Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A(4). Nat. Med. 8, 1018-1023.
65. Grumbach, Y., Quynh, N.V., Chiron, R., and Urbach, V. (2009) LXA4 stimulates ZO-1 expression and transepithelial electrical resistance in human airway epithelial (16HBE14o-) cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 296, L101-108.
66. Celik, G.E., Erkekol, F.O., Misirligil, Z., and Melli, M. (2007) Lipoxin A4 levels in asthma: relation with disease severity and aspirin sensitivity. Clin. Exp. Allergy 37, 1494-1501.
67. Bonnans, C., Fukunaga, K., Levy, M.A., and Levy, B.D. (2006) Lipoxin A(4) regulates bronchial epithelial cell responses to acid injury. Am. J. Pathol. 168, 1064-1072.
68. El Kebir, D., József, L., Pan, W., Wang, L., Petasis, N.A., Serhan, C.N., and Filep, J.G. (2009) 15-Epi-lipoxin A4 inhibits myeloperoxidase signaling and enhances resolution of acute lung injury. Am. J. Respir. Crit. Care Med. 180, 311-319.
69. Jin, S.W., Zhang, L., Lian, Q.Q., Liu, D., Wu, P., Yao, S.L., and Ye, D.Y. (2007) Posttreatment with aspirin-triggered lipoxin A4 analog attenuates lipopolysaccharide-induced acute lung injury in mice: the role of heme oxygenase-1. Anesth. Analg. 104, 369-377.
70. Karp, C.L., Flick, L.M., Park, K.W., Softic, S., Greer, T.M., Keledjian, R., Yang, R., Uddin, J., Guggino, W.B., Atabani, S.F., Belkaid, Y., Xu, Y., Whitsett, J.A., Accurso, F.J., Wills-Karp, M., and Petasis, N.A. (2004) Defective lipoxin-mediated anti-inflammatory activity in the cystic fibrosis airway. Nat. Immunol. 5, 388-392.
71. Chiron, R., Grumbach, Y.Y., Quynh, N.V., Verriere, V., and Urbach, V. (2008) Lipoxin A(4) and interleukin-8 levels in cystic fibrosis sputum after antibiotherapy. J. Cyst. Fibros. 7, 463-468.
72. Hashimoto, A., Hayashi, I., Murakami, Y., Sato, Y., Kitasato, H., Matsushita, R., Iizuka, N., Urabe, K., Itoman, M., Hirohata, S., and Endo, H. (2007) Antiinflammatory mediator lipoxin A4 and its receptor in synovitis of patients with rheumatoid arthritis. J. Rheumatol. 34, 2144-2153.
73. Zhang, L., Zhang, X., Wu, P., Li, H., Jin, S., Zhou, X., Li, Y., Ye, D., Chen, B., and Wan, J. (2008) BML-111, a lipoxin receptor agonist, modulates the immune response and reduces the severity of collagen-induced arthritis. Inflamm. Res. 57, 157-162.
74. Fiorucci, S., de Lima, O.M., Jr., Mencarelli, A., Palazzetti, B., Distrutti, E., McKnight, W., Dicay, M., Ma, L., Romano, M., Morelli, A., and Wallace, J.L. (2002) Cyclooxygenase-2-derived lipoxin A4 increases gastric resistance to aspirin-induced damage. Gastroenterology 123, 1598-1606.
75. Fiorucci, S., Distrutti, E., de Lima, O.M., Romano, M., Mencarelli, A., Barbanti, M., Palazzini, E., Morelli, A., and Wallace, J.L. (2003) Relative contribution of acetylated cyclo-oxygenase (COX)-2 and 5-lipooxygenase (LOX) in regulating gastric mucosal integrity and adaptation to aspirin. FASEB J. 17, 1171-1173.
76. Renda, G., Zurro, M., Romano, M., and De Caterina, R. (2010) Aspirin-triggered lipoxin in patients treated with aspirin and selective vs. nonselective COX-2 inhibitors. Br. J. Clin. Pharmacol. 69, 303-306.
77. Peskar, B.M., Ehrlich, K., Schuligoi, R., and Peskar, B.A. (2009) Role of lipoxygenases and lipoxin A(4)/annexin-1 receptor in gastric protection induced by 20% ethanol or sodium salicylate in rats. Pharmacology 84, 310-313.
78. Peskar, B.M., Ehrlich, K., Schuligoi, R., and Peskar, B.A. (2009) Role of lipoxygenases and the lipoxin A(4)/annexin 1 receptor in ischemia-reperfusion- induced gastric mucosal damage in rats. Pharmacology 84, 294-299.
79. Goh, J., Baird, A.W., O'Keane, C., Watson, R.W., Cottell, D., Bernasconi, G., Petasis, N.A., Godson, C., Brady, H.R., and MacMathuna, P. (2001) Lipoxin A(4) and aspirin-triggered 15-epi-lipoxin A(4) antagonize TNF-alpha-stimulated neutrophil-enterocyte interactions in vitro and attenuate TNF-alpha-induced chemokine release and colonocyte apoptosis in human intestinal mucosa ex vivo. J. Immunol. 167, 2772-2780.
80. Gewirtz, A.T., Collier-Hyams, L.S., Young, A.N., Kucharzik, T., Guilford, W.J., Parkinson, J.F., Williams, I.R., Neish, A.S., and Madara, J.L. (2002) Lipoxin a4 analogs attenuate induction of intestinal epithelial proinflammatory gene expression and reduce the severity of dextran sodium sulfate-induced colitis. J. Immunol. 168, 5260-5267.
81. Fiorucci, S, Wallace, J.L., Mencarelli, A., Distrutti, E., Rizzo, G., Farneti, S., Morelli, A., Tseng, J.-L., Suramanyam, B., Guilford, W.J., and Parkinson, J.F. (2004) A beta-oxidation-resistant lipoxin A4 analog treats hapten-induced colitis by attenuating inflammation and immune dysfunction. Proc. Natl. Acad. Sci. U. S. A. 101, 15736-15741.
82. Gronert, K., Gewirtz, A., Madara, J.L., and Serhan, C.N. (1998) Identification of a human enterocyte lipoxin A4 receptor that is regulated by interleukin (IL)-13 and interferon gamma and inhibits tumor necrosis factor alpha-induced IL-8 release. J. Exp. Med. 187, 1285-1294.
83. Kucharzik, T., Gewirtz, A.T., Merlin, D., Madara, J.L., and Williams, I.R. (2003) Lateral membrane LXA4 receptors mediate LXA4's anti-inflammatory actions on intestinal epithelium. Am. J. Physiol. Cell Physiol. 284, C888-896.
84. Kure, I., Nishiumi, S., Nishitani, Y., Tanoue, T., Ishida, T., Mizuno, M., Fujita, T., Kutsumi, H., Arita, M., Azuma, T., and Yoshida, M. (2010) Lipoxin A(4) reduces lipopolysaccharide-induced inflammation in macrophages and intestinal epithelial cells through inhibition of nuclear factor-kappaB activation. J. Pharmacol. Exp. Ther. 332, 541-548.
85. Badr, K.F., DeBoer, D.K., Schwartzberg, M., and Serhan, C.N. (1987) Lipoxin A4 antagonizes cellular and in vivo actions of leukotriene D4 in rat glomerular mesangial cells: evidence for competition at a common receptor. Proc. Natl. Acad. Sci. U. S. A. 86, 3438-3442.
86. Brady, H.R., Persson, U., Ballermann, B.J., Brenner, B.M., and Serhan, C.N. (1990) Leukotrienes stimulate neutrophil adhesion to mesangial cells: modulation with lipoxins. Am. J. Physiol. 259, F809-815.
87. McMahon, B., Stenson, C., McPhillips, F., Fanning, A., Brady, H.R., and Godson, C. (2000) Lipoxin A4 antagonizes the mitogenic effects of leukotriene D4 in human renal mesangial cells. Differential activation of MAP kinases through distinct receptors. J. Biol. Chem. 275, 27566-27575.
88. McMahon, B., Mitchell, D., Shattock, R., Martin, F., Brady, H.R., and Godson, C. (2002) Lipoxin, leukotriene, and PDGF receptors cross-talk to regulate mesangial cell proliferation. FASEB J. 16, 1817-1819.
89. Mitchell, D., Rodgers, K., Hanly, J., McMahon, B., Brady, H.R., Martin, F., and Godson, C. (2004) Lipoxins inhibit Akt/PKB activation and cell cycle progression in human mesangial cells. Am. J. Pathol. 164, 937-946.
90. Wu, S.H., Wu, X.H., Lu, C., Dong, L., Zhou, G.P., and Chen, Z.Q. (2006) Lipoxin A4 inhibits connective tissue growth factor-induced production of chemokines in rat mesangial cells. Kidney Int. 69, 248-256.
91. Leonard, M.O., Hannan, K., Burne, M.J., Lappin, D.W., Doran, P., Coleman, P., Stenson, C., Taylor, C.T., Daniels, F., Godson, C., Petasis, N.A., Rabb, H., and Brady, H.R. (2002) 15-Epi-16-(para-fluorophenoxy)-lipoxin A(4)-methyl ester, a synthetic analogue of 15-epi-lipoxin A(4), is protective in experimental ischemic acute renal failure. J. Am. Soc. Nephrol. 13, 1657-1662.
92. Kieran, N.E., Doran, P.P., Connolly, S.B., Greenan, M.C., Higgins, D.F., Leonard, M., Godson, C., Taylor, C.T., Henger, A., Kretzler, M., Burne, M.J., Rabb, H., and Brady, H.R. (2003) Modification of the transcriptomic response to renal ischemia/reperfusion injury by lipoxin analog. Kidney Int. 64, 480-492.
93. Leedom, A.J., Sullivan, A.B., Dong, B., Lau, D., and Gronert, K. (2010) Endogenous LXA4 circuits are determinants of pathological angiogenesis in response to chronic injury. Am. J. Pathol. 176, 74-84.
94. Gronert, K., Maheshwari, N., Khan, N., Hassan, I.R., Dunn, M., and Laniado Schwartzman, M. (2005) A role for the mouse 12/15-lipoxygenase pathway in promoting epithelial wound healing and host defense. J. Biol. Chem. 280, 15267-15278.
95. Biteman, B., Hassan, I.R., Walker, E., Leedom, A.J., Dunn, M., Seta, F., Laniado-Schwartzman, M., and Gronert, K. (2007) Interdependence of lipoxin A4 and heme-oxygenase in counter-regulating inflammation during corneal wound healing. FASEB J. 21, 2257-2266.
96. Medeiros, R., Rodrigues, G.B., Figueiredo, C.P., Rodrigues, E.B., Grumman, A., Jr., Menezes-de-Lima, O., Jr., Passos, G.F., and Calixto, J.B. (2008) Molecular mechanisms of topical anti-inflammatory effects of lipoxin A(4) in endotoxin-induced uveitis. Mol. Pharmacol. 74, 154-161.
97. Jin, Y., Arita, M., Zhang, Q., Saban, D.R., Chauhan, S.K., Chiang, N., Serhan, C.N., and Dana, R. (2009) Antiangiogenesis effect of the novel anti-inflammatory and pro-resolving lipid mediators. Invest. Ophthalmol. Vis. Sci. 50, 4743-4752.
98. Leedom, A.J., Sullivan, A.B., Dong, B., Lau, D., and Gronert, K. (2010) Endogenous LXA4 circuits are determinants of pathological angiogenesis in response to chronic injury. Am. J. Pathol. 176, 74-84.
99. Brezinski, M.E., Gimbrone, M.A., Jr., Nicolaou, K.C., and Serhan, C.N. (1989) Lipoxins stimulate prostacyclin generation by human endothelial cells. FEBS Lett. 245, 167-172.
100. Lefer, A.M., Stahl, G.L., Lefer, D.J., Brezinski, M.E., Nicolaou, K.C., Veale, C.A., Abe, Y., and Smith, J.B. (1988) Lipoxins A4 and B4: comparison of icosanoids having bronchoconstrictor and vasodilator actions but lacking platelet aggregatory activity. Proc. Natl. Acad. Sci. U. S. A. 85, 8340-8344.
101. Paul-Clark, M.J., Van Cao, T., Moradi-Bidhendi, N., Cooper, D., and Gilroy, D.W. (2004) 15-Epi-lipoxin A4-mediated induction of nitric oxide explains how aspirin inhibits acute inflammation. J. Exp. Med. 200, 69-78.
102. Nascimento-Silva, V., Arruda, M.A., Barja-Fidalgo, C., and Fierro, I.M. (2007) Aspirin-triggered lipoxin A4 blocks reactive oxygen species generation in endothelial cells: a novel antioxidative mechanism. Thromb. Haemost. 97, 88-98.
103. Fierro, I.M., Kutok, J.L., and Serhan, C.N. (2002) Novel lipid mediator regulators of endothelial cell proliferation and migration: aspirin-triggered- 15R-lipoxin A(4) and lipoxin A(4). J. Pharmacol. Exp. Ther. 300, 385-392.
104. Cezar-de-Mello, P.F., Nascimento-Silva, V., Villela, C.G., and Fierro, I.M. (2006) Aspirin-triggered lipoxin A4 inhibition of VEGF-induced endothelial cell migration involves actin polymerization and focal adhesion assembly. Oncogene 25, 122-129.
105. Merched, A.J., Ko, K., Gotlinger, K.H., Serhan, C.N., and Chan, L. (2008) Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators. FASEB J. 22, 3595-3606.
106. Aliberti, J., Hieny, S., Reis e Sousa, C., Serhan, C.N., and Sher, A. (2002) Lipoxin-mediated inhibition of IL-12 production by DCs: a mechanism for regulation of microbial immunity. Nat. Immunol. 3, 76-82.
107. Aliberti, J., Serhan, C., Sher, A. (2002) Parasite-induced lipoxin A4 is an endogenous regulator of IL-12 production and immunopathology in Toxoplasma gondii infection. J. Exp. Med. 196, 1253-1262. (Pubitemid 35304190)
108. Bannenberg, G.L., Aliberti, J., Hong, S., Sher, A., and Serhan, C. (2004) Exogenous pathogen and plant 15-lipoxygenase initiate endogenous lipoxin A4 biosynthesis. J. Exp. Med. 199, 515-523.
109. Bafica, A., Scanga, C.A., Serhan, C., Machado, F., White, S., Sher, A., and Aliberti, J. (2005) Host control of Mycobacterium tuberculosis is regulated by 5-lipoxygenase-dependent lipoxin production. J. Clin. Invest. 115, 1601-1606.
110. Chen, M., Divangahi, M., Gan, H., Shin, D.S., Hong, S., Lee, D.M., Serhan, C.N., Behar, S.M., and Remold, H.G. (2008) Lipid mediators in innate immunity against tuberculosis: opposing roles of PGE2 and LXA4 in the induction of macrophage death. J. Exp. Med. 205, 2791-12801.
111. Pouliot, M., Clish, C.B., Petasis, N.A., Van Dyke, T.E., and Serhan, C.N. (2000) Lipoxin A(4) analogues inhibit leukocyte recruitment to Porphyromonas gingivalis: a role for cyclooxygenase-2 and lipoxins in periodontal disease. Biochemistry 39, 4761-4768.
112. Serhan, C.N., Jain, A., Marleau, S., Clish, C., Kantarci, A., Behbehani, B., Colgan, S.P., Stahl, G.L., Merched, A., Petasis, N.A., Chan, L., and Van Dyke, T.E. (2003) Reduced inflammation and tissue damage in transgenic rabbits overexpressing 15-lipoxygenase and endogenous anti-inflammatory lipid mediators. J. Immunol. 171, 6856-6865.
113. Chiang, N., Gronert, K., Clish, C.B., O'Brien, J.A., Freeman, M.W., and Serhan, C.N. (1999) Leukotriene B4 receptor transgenic mice reveal novel protective roles for lipoxins and aspirin-triggered lipoxins in reperfusion. J. Clin. Invest. 104, 309-316.
114. Planaguma, A., Titos, E., Lopez-Parra, M., Gaya, J., Puedo, G., Arroyo, V., and Claria, J. (2002) Aspirin (ASA) regulates 5-lipoxygenase activity and peroxisome proliferator-activated receptor alpha-mediated CINC-1 release in rat liver cells: novel actions of lipoxin A4 (LXA4) and ASA-triggered 15-epi-LXA4. FASEB J. 16, 1937-1939.
115. Ye, X.H., Wu, Y., Guo, P.P., Wang, J., Yuan, S.Y., Shang, Y., and Yao, S.L. (2010) Lipoxin A(4) analogue protects brain and reduces inflammation in a rat model of focal cerebral ischemia reperfusion. Brain Res. [Epub ahead of print]
116. Souza, D.G., Fagundes, C.T., Amaral, F.A., Cisalpino, D., Sousa, L.P., Vieira, A.T., Pinho, V., Nicoli, J.R., Vieira, L.Q., Fierro, I.M., and Teixeira, M.M. (2007) The required role of endogenously produced lipoxin A4 and annexin-1 for the production of IL-10 and inflammatory hyporesponsiveness in mice. J. Immunol. 179, 8533-8543.
117. Fiore, S., Maddox, J.F., Perez, H.D., and Serhan, C.N. (1994) Identification of a human cDNA encoding a functional high affinity lipoxin A4 receptor. J. Exp. Med. 180, 253-260.
118. Takano, T., Fiore, S., Maddox, J.F., Brady, H.R., Petasis, N.A., and Serhan, C.N. (1997) Aspirin-triggered 15-epilipoxin A4 (LXA4) and LXA4 stable analogues are potent inhibitors of acute inflammation: evidence for antiinflammatory receptors. J. Exp. Med. 185, 1693-1704.
119. Ye, R.D., Boulay, F., Wang, J.M., Dahlgren, C., Gerard, C., Parmentier, M., Serhan, C.N., and Murphy, P.M. (2009) International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family. Pharmacol. Rev. 61, 119-161.
120. Romano, M., Recchia, I., and Recchiuti, A. (2007) Lipoxin receptors. TheScientificWorldJOURNAL 7, 1393-1412.
121. Krishnamoorthy, S., Recchiuti, A., Chiang, N., Yacoubian, S., Lee, C.H., Yang, R., Petasis, N.A., and Serhan, C.N. (2010) Resolvin D1 binds human phagocytes with evidence for proresolving receptors. Proc. Natl. Acad. Sci. U. S. A. 107, 1660-1665.
122. Devchand, P.R., Arita, M., Hong, S., Bannenberg, G., Moussignac, R.L., Gronert, K., and Serhan, C.N. (2003) Human ALX receptor regulates neutrophil recruitment in transgenic mice: roles in inflammation and host defense. FASEB J. 17, 652-659.
123. Dufton, N., Hannon, R., Brancaleone, V., Dalli, J., Patel, H.B., Gray, M., D'Acquisto, F., Buckingham, J.C., Perretti, M., and Flower, R.J. (2010) Anti-inflammatory role of the murine formyl-peptide receptor 2: ligand-specific effects on leukocyte responses and experimental inflammation. J. Immunol. 184, 2611-2619.